Skip to main content
Top
Published in: Journal of Bone and Mineral Metabolism 5/2016

01-09-2016 | Case Report

Characterization of an acromesomelic dysplasia, Grebe type case: novel mutation affecting the recognition motif at the processing site of GDF5

Authors: Monica Martinez-Garcia, Eva Garcia-Canto, Maria Fenollar-Cortes, Antonio Perez Aytes, María José Trujillo-Tiebas

Published in: Journal of Bone and Mineral Metabolism | Issue 5/2016

Login to get access

Abstract

Acromesomelic dysplasia, Grebe type is a very rare skeletal dysplasia characterized by severe dwarfism with marked micromelia and deformation of the upper and lower limbs, with a proximodistal gradient of severity. CDMP1 gene mutations have been associated with Grebe syndrome, Hunter–Thompson syndrome, Du Pan syndrome and brachydactyly type C. The proband is a 4-year-old boy, born of consanguineous Pakistani parents. Radiographic imaging revealed features typical of Grebe syndrome: severe shortening of the forearms with an acromesomelic pattern following a proximodistal gradient, with distal parts more severely affected than medial parts; hypoplastic hands, with the phalangeal zone more affected than the metacarpal zone; and severe hypoplastic tibial/femoral zones in both limbs. After molecular analyses, the p.Arg377Trp variant in a homozygous pattern was identified in the CDMP1 gene in the affected child. In silico and structural analyses predicted the p.Arg377Trp amino acid change to be pathogenic. Of the 34 mutations described in the CDMP1 gene, four different missense mutations have been associated with Grebe syndrome. The CDMP1 gene encodes growth differentiation factor 5 (GDF5), which plays a role in regulation of limb patterning, joint formation and distal bone growth. Homozygous mutations in the mature domain of GDF5 result in severe limb malformations such as the Grebe type or the Hunter–Thompson type of acromesomelic chondrodysplasia. The p.Arg377Trp mutation is located within the recognition motif at the processing site of GDF5 where the sequence RRKRR changes to WRKRR. The genotype–phenotype correlation allowed not only confirmation of the clinical diagnosis but also appropriate genetic counselling to be offered to this family.
Literature
1.
go back to reference Costa T, Ramsby G, Cassia F et al (1998) Grebe syndrome: clinical and radiographic findings in affected individuals and heterozygous carriers. Am J Med Genet 75:523–529CrossRefPubMed Costa T, Ramsby G, Cassia F et al (1998) Grebe syndrome: clinical and radiographic findings in affected individuals and heterozygous carriers. Am J Med Genet 75:523–529CrossRefPubMed
2.
go back to reference Thomas JT, Kilpatrick MW, Lin K et al (1997) Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1. Nat Genet 17:58–64CrossRefPubMed Thomas JT, Kilpatrick MW, Lin K et al (1997) Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1. Nat Genet 17:58–64CrossRefPubMed
3.
go back to reference Chang SC, Hoang B, Thomas JT et al (1994) Cartilage-derived morphogenetic proteins. New members of the transforming growth factor-beta superfamily predominantly expressed in long bones during human embryonic development. J Biol Chem 269:28227–28234PubMed Chang SC, Hoang B, Thomas JT et al (1994) Cartilage-derived morphogenetic proteins. New members of the transforming growth factor-beta superfamily predominantly expressed in long bones during human embryonic development. J Biol Chem 269:28227–28234PubMed
4.
go back to reference Francis-West P, Abdelfattah A, Chen P et al (1999) Mechanisms of GDF-5 action during skeletal development. Development 126:1305–1315PubMed Francis-West P, Abdelfattah A, Chen P et al (1999) Mechanisms of GDF-5 action during skeletal development. Development 126:1305–1315PubMed
6.
Metadata
Title
Characterization of an acromesomelic dysplasia, Grebe type case: novel mutation affecting the recognition motif at the processing site of GDF5
Authors
Monica Martinez-Garcia
Eva Garcia-Canto
Maria Fenollar-Cortes
Antonio Perez Aytes
María José Trujillo-Tiebas
Publication date
01-09-2016
Publisher
Springer Japan
Published in
Journal of Bone and Mineral Metabolism / Issue 5/2016
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-015-0693-z

Other articles of this Issue 5/2016

Journal of Bone and Mineral Metabolism 5/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine